Measurement of colony-stimulating factors in synovial fluid: potential clinical value

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Rheumatology International

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00262295PMID 7536953
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Granulocyte-macrophage colony-stimulating factor augments neutrophil-mediated cartilage degradation and neutrophil adherence.

  2010cited by this paper
• Colony stimulating factor occurs in both inflammatory and noninflammatory synovial fluids

  2005cited by this paper
• Production of macrophage colony-stimulating factor (M-CSF) by human monocytes is differentially regulated by GM-CSF, TNF alpha, and IFN-gamma.

  1992cited by this paper
• Cytokine inter-relationships and their association with disease activity in arthritis.

  1992cited by this paper
• Cytokine regulation of colony-stimulating factor (CSF) production in cultured human synovial fibroblasts. II. Similarities and differences in the control of interleukin-1 induction of granulocyte-macrophage CSF and granulocyte-CSF production.

  1992cited by this paper
• Cytokine measurements in biological fluids.

  1992cited by this paper
• Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair.

  1992cited by this paper
• Characteristics of immunocompetent cells in synovial membranes from multiple sites in patients with rheumatoid arthritis.

  1992cited by this paper
• Production of macrophage colony-stimulating factor (M-CSF) by human monocytes is differentially regulated by GM-CSF, TNFα, and IFN-γ

  1992cited by this paper
• Normal unstimulated lymphocytes produce granulopoietic inhibitory activity.

  1991cited by this paper
• Cytokines in chronic inflammatory arthritis. VI. Analysis of the synovial cells involved in granulocyte-macrophage colony-stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor necrosis factor-alpha.

  1991cited by this paper
• Expression of granulocyte‐macrophage colony‐stimulating factor in rheumatoid arthritis: Regulation by tumor necrosis factor‐α

  1991cited by this paper
• Molecular physiology of granulocyte-macrophage colony-stimulating factor.

  1991cited by this paper
• Granulocyte-macrophage colony stimulating factor induces both HLA-DR expression and cytokine production by human monocytes.

  1990cited by this paper
• Revised criteria for the classification of rheumatoid arthritis.

  1990cited by this paper
• Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes.

  1990cited by this paper
• Cytokines in chronic inflammatory arthritis. IV. Granulocyte/macrophage colony-stimulating factor-mediated induction of class II MHC antigen on human monocytes: a possible role in rheumatoid arthritis

  1989cited by this paper
• Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions.

  1989cited by this paper
• Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis

  1988cited by this paper
• The detection and initial characterization of colony-stimulating factors in synovial fluid.

  1988cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• Human umbilical cord conditioned medium: a stimulus for human CFU-G.

  1984cited by this paper
• CYTOKINES IN CHRONIC INFLAMMATORY ARTHRITIS

  year unknowncited by this paper

• Extensive study of CCN4, VCAM-1, MMP-3, and GM-CSF as reliable markers for disease activity in rheumatoid arthritis

  2024cites this paper
• Distinct fibroblast functions associated with fibrotic and immune-mediated inflammatory diseases and their implications for therapeutic development

  2024cites this paper
• Can serum granulocyte-macrophage colony-stimulating factor and CCL17 levels be a marker of disease activation in spondyloarthritis?

  2024cites this paper
• Non-TNF biologics and their biosimilars in rheumatoid arthritis

  2024cites this paper
• Methotrexate promotes the release of granulocyte–macrophage colony-stimulating factor from rheumatoid arthritis fibroblast-like synoviocytes via autocrine interleukin-1 signaling

  2024cites this paper
• Global scientific trends update on macrophage polarization in rheumatoid arthritis: A bibliometric and visualized analysis from 2000 to 2022

  2023cites this paper
• An Update on the Emerging Role of Wnt/β-catenin, SYK, PI3K/AKT, and GM-CSF Signaling Pathways in Rheumatoid Arthritis.

  2023cites this paper
• Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs: two phase 3 randomised trials (contRAst 1 and contRAst 2)

  2023cites this paper
• Hyaluronic Acid in Synovial Fluid Prevents Neutrophil Activation in Spondyloarthritis

  2023cites this paper
• An update on novel therapeutic intervention in Rheumatoid arthritis.

  2022cites this paper
• Chronic pharmacological antagonism of murine GM-CSF-R-alpha does not replicate the Pulmonary Alveolar Proteinosis phenotype but does alter lung surfactant turnover.

  2021cites this paper
• Therapies Targeting Trained Immune Cells in Inflammatory and Autoimmune Diseases

  2021cites this paper
• GM-CSF Primes Proinflammatory Monocyte Responses in Ankylosing Spondylitis

  2020cites this paper
• Safety and Efficacy of Mavrilimumab For Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.

  2020cites this paper
• Mavrilimumab: a unique insight and update on the current status in the treatment of rheumatoid arthritis

  2019cites this paper
• Liver fibrosis and CD206+ macrophage accumulation are suppressed by anti-GM-CSF therapy

  2019influential citation
• Who's in charge here? Macrophage colony stimulating factor and granulocyte macrophage colony stimulating factor: Competing factors in macrophage polarization.

  2019cites this paper
• Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future Prospects

  2019cites this paper
• GM-CSF, IL-3, and IL-5 Family of Cytokines: Regulators of Inflammation.

  2019cites this paper
• A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis

  2017cites this paper
• Selected cytokine pathways in rheumatoid arthritis

  2017cites this paper
• A randomised phase IIb study of mavrilimumab, a novel GM–CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis

  2017cites this paper
• Future therapeutic targets in rheumatoid arthritis?

  2017cites this paper
• Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathways

  2017cites this paper
• Targeting GM-CSF in rheumatoid arthritis.

  2016cites this paper
• Pulmonary pharmacodynamics of an anti-GM-CSFRα antibody enables therapeutic dosing that limits exposure in the lung

  2016cites this paper
• Pathogene Zellen der rheumatischen Entzündung als Ziele moderner Therapien

  2015cites this paper
• Efficacy and safety of mavrilimumab in Japanese subjects with rheumatoid arthritis: Findings from a Phase IIa study

  2015cites this paper
• A Promising Target in Rheumatoid Arthritis Treatment: Granulocyte-Macrophage Colony-Stimulating Factor

  2015cites this paper
• Investigating the role of microRNA in inflammatory cytokine production of macrophages in rheumatoid arthritis

  2015influential citation
• [Pathogenic cells of rheumatic inflammation as the target of modern therapies].

  2015cites this paper
• The rheumatoid joint

  2014cites this paper
• Paeonol inhibited TNFα-induced GM-CSF expression in fibroblast-like synoviocytes.

  2014cites this paper
• Emerging immunotherapies for rheumatoid arthritis

  2014cites this paper
• Protein engineering and preclinical development of a GM‐CSF receptor antibody for the treatment of rheumatoid arthritis

  2013cites this paper
• GM-CSF as a therapeutic target in inflammatory diseases.

  2013cites this paper
• Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis

  2012cites this paper
• Mechanistic Modeling of Antigen Sink Effect for Mavrilimumab Following Intravenous Administration in Patients With Rheumatoid Arthritis

  2012cites this paper
• Characterisation of cytokine expression in early synovitis and established rheumatoid arthritis

  2012cites this paper
• The proinflammatory cytokine GM-CSF downregulates fetal hemoglobin expression by attenuating the cAMP-dependent pathway in sickle cell disease.

  2011cites this paper
• Increased expression of S100 calcium binding protein A8 in GM-CSF-stimulated neutrophils leads to the increased expressions of IL-8 and IL-16.

  2011cites this paper
• Implication of granulocyte-macrophage colony-stimulating factor induced neutrophil gelatinase-associated lipocalin in pathogenesis of rheumatoid arthritis revealed by proteome analysis

  2009cites this paper
• Marqueurs sériques prédisant la réponse clinique à des anticorps anti-tnf chez les patients souffrant de spondylarthrite ankylosante

  2009cites this paper
• Activation of FcγRI on Monocytes Triggers Differentiation into Immature Dendritic Cells That Induce Autoreactive T Cell Responses1

  2009cites this paper
• In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification.

  2008cites this paper
• Leukocyte numbers correlate with plasma levels of granulocyte–macrophage colony-stimulating factor in sickle cell disease

  2007cites this paper
• NSAIDs increase GM-CSF release by human synoviocytes: comparison with nitric oxide-donating derivatives.

  2005cites this paper
• Comparison of the activities of multinucleated bone-resorbing giant cells derived from CD14-positive cells in the synovial fluids of rheumatoid arthritis and osteoarthritis patients.

  2004cites this paper
• Expression of the dendritic cell-associated C-type lectin DC-SIGN by inflammatory matrix metalloproteinase-producing macrophages in rheumatoid arthritis synovium and interaction with intercellular adhesion molecule 3-positive T cells.

  2003cites this paper
• Colony stimulating factor-1 in synovial fluids from osteoarthritic and injured knees

  1998cites this paper
• Neurogenic diabetes insipidus in patients with systemic lupus erythematosus

  1998cites this paper
• Orderly arrayed deposit of urate crystals in gout suggest epitaxial formation

  1998cites this paper
• Human blood and synovial fluid neutrophils cultured in vitro undergo programmed cell death which is promoted by the addition of synovial fluid.

  1995cites this paper